BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10530958)

  • 1. Resolution, molecular structure and biological activities of the D- and L-enantiomers of potent anti-implantation agent, DL-2-[4-(2-piperidinoethoxy)phenyl]-3-phenyl-2H-1-benzopyran.
    Hajela K; Pandey J; Dwivedy A; Dhar JD; Sarkhel S; Maulik PR; Velumurugan D
    Bioorg Med Chem; 1999 Sep; 7(9):2083-90. PubMed ID: 10530958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure activity relationship of some 2,3-diaryl-2H-1-benzopyrans to their anti-implantation, estrogenic and antiestrogenic activities in rat.
    Dhar JD; Dwivedi A; Srivastava A; Setty BS
    Contraception; 1994 Jun; 49(6):609-16. PubMed ID: 8070266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship of antiestrogens. Phenolic analogues of 2,3-diaryl-2H-1-benzopyrans.
    Sharma AP; Saeed A; Durani S; Kapil RS
    J Med Chem; 1990 Dec; 33(12):3222-9. PubMed ID: 2258908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans.
    Sharma AP; Saeed A; Durani S; Kapil RS
    J Med Chem; 1990 Dec; 33(12):3216-22. PubMed ID: 2258907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological profile of 2-[4-(2-N-piperidinoethoxy) phenyl]-3-phenyl (2H) benzo (b) pyran--a potent antiimplantation agent in rat.
    Dhar JD; Setty BS; Duran S; Kapil RS
    Contraception; 1991 Oct; 44(4):461-72. PubMed ID: 1824558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen.
    Gauthier S; Caron B; Cloutier J; Dory YL; Favre A; Larouche D; Mailhot J; Ouellet C; Schwerdtfeger A; Leblanc G; Martel C; Simard J; Mérand Y; Bélanger A; Labrie C; Labrie F
    J Med Chem; 1997 Jul; 40(14):2117-22. PubMed ID: 9216828
    [No Abstract]   [Full Text] [Related]  

  • 7. Antifertility potential of 2-[piperdinoethoxyphenyl]-3-[4- methoxyphenyl]-2H benzopyran: a potent anti-oestrogenic compound in rats.
    Singh R
    J Reprod Fertil; 1996 Jan; 106(1):49-53. PubMed ID: 8667345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissue.
    Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
    J Pharmacol Exp Ther; 2002 Mar; 300(3):802-9. PubMed ID: 11861784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDRI-85/287, a novel antiestrogen and antiimplantation agent: biological profile and interaction with the estrogen receptors in immature rat uterus.
    Sreenivasulu S; Singh MM; Dwivedi A; Setty BS; Kamboj VP
    Contraception; 1992 Jan; 45(1):81-92. PubMed ID: 1591925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDRI-85/287: studies on competition to estrogen binding sites in the immature rat uterus.
    Sreenivasulu S; Dwivedi A; Singh MM; Setty BS; Kamboj VP
    Indian J Exp Biol; 1992 Dec; 30(12):1115-7. PubMed ID: 1294475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of antiestrogenecity of compound CDRI-85/287: a new orally active nonsteroidal antiimplantation agent.
    Sreenivasulu S; Singh MM; Dwivedi A; Setty BS; Kamboj VP
    Indian J Exp Biol; 1992 Nov; 30(11):968-71. PubMed ID: 1293041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of CDRI-85/287, a potent antiimplantation agent on uterine endometrial dimensions and peroxidase levels in rat.
    Gupta S; Dhar JD; Bansode FW; Setty BS
    Indian J Exp Biol; 1998 May; 36(5):464-9. PubMed ID: 9717463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship of antiestrogens. Studies on 2,3-diaryl-1-benzopyrans.
    Saeed A; Sharma AP; Durani N; Jain R; Durani S; Kapil RS
    J Med Chem; 1990 Dec; 33(12):3210-6. PubMed ID: 2258906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a pure nonsteroidal antiestrogen, CDRI-85/287, on implantation--associated histological and biochemical changes in the rat uterus.
    Sreenivasulu S; Singh MM; Setty BS; Kamboj VP
    Contraception; 1993 Dec; 48(6):597-609. PubMed ID: 7510597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological actions of a novel, potent, tissue-selective benzopyran estrogen.
    Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
    J Pharmacol Exp Ther; 2002 Oct; 303(1):196-203. PubMed ID: 12235251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-implantation effect of 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran, a potent antiestrogenic agent in rats.
    Kharkwal G; Fatima I; Kitchlu S; Singh B; Hajela K; Dwivedi A
    Fertil Steril; 2011 Mar; 95(4):1322-7. PubMed ID: 20674906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies in antifertility agents. 50. Stereoselective binding of d- and l-centchromans to estrogen receptors and their antifertility activity.
    Salman M; Ray S; Anand N; Agarwal AK; Singh MM; Setty BS; Kamboj VP
    J Med Chem; 1986 Sep; 29(9):1801-3. PubMed ID: 3746826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a new anti-oestrogen and anti-implantation agent, CDRI-85/287, on tubal transport, development and viability of rat embryos.
    Sreenivasulu S; Singh MM; Kamboj VP
    Reprod Fertil Dev; 1994; 6(2):241-6. PubMed ID: 7991794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in uterine ornithine decarboxylase activity and steroid receptor levels during decidualization in the rat induced by CDRI-85/287.
    Dwivedi A; Gupta G; Keshri G; Dhar JD
    Eur J Endocrinol; 1999 Oct; 141(4):426-30. PubMed ID: 10526259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.